Glenmark Pharmaceuticals shares tumble nearly 6% over alleged false claims about ‘FabiFlu’
New Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetails
New Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals announced Tuesday that it will commence another new Phase 3 clinical trial. This will be on ...
Read moreDetails
By Dilip Cherian The controversy surrounding Odisha’s next DGP is not really about Sanjeeb Panda or others in the race....
Read moreDetails
There are tell-tale signs that the BJP has been shaken to its core following the upsurge of protests by the...
Read moreDetails
It is a happy augury for Indian democracy that the country's young talents aspiring to join the legal profession have...
Read moreDetails
In any democracy, the most disturbing threat to freedom is not always censorship. Sometimes it is the language used to...
Read moreDetails